Join the club for FREE to access the whole archive and other member benefits.

Big data promise exponential change in healthcare


Key points from article :

GlaxoSmithKline employs online technology and a data algorithm developed by F1’s elite McLaren Applied Technologies team.

Potential lies in its ability to fine tune research and clinical trials.

Helped by continued falls in data storage costs and improving computing power.

Handling the personal details of millions of people creates huge data quality, privacy and security problems.

Data gathered 10 years ago by a brain scan is infinitely less detailed than what you would get today

Mentioned in this article:

Click on resource name for more details.

Brian Neill

Head of Technical, Respiratory & HIV at GSK.


Company developing AI systems for solving problems.

Doug Given

Managing Partner at Health2047 Capital Partners

GlaxoSmithKline (GSK)

Research and develop pharmaceutical medicines, vaccines and consumer healthcare products


Global medicines company for developing and producing drugs.

Stephen Cleaver

Head of informatics systems at Novartis Institutes for Biomedical Research in Cambridge.

Topics mentioned on this page:
AI in Healthcare